JESÚS FERNANDO
SAN MIGUEL IZQUIERDO
Ikertzailea 1986-2013 tartean
Medical University of Silesia
Katowice, PoloniaMedical University of Silesia-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2020
-
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Blood Cancer Journal, Vol. 10, Núm. 9